Zeiler Michael, Dietzel Nikolas, Kammerer Klaus, Frick Ulrich, Pryss Rüdiger, Heuschmann Peter, Prokosch Hans-Ulrich, Graessel Elmar, Kolominsky-Rabas Peter L
Institute for Medical Informatics, Biometrics and Epidemiology, Medical Informatics, Friedrich-Alexander-Universität Erlangen-Nürnberg, Erlangen, Germany.
Interdisciplinary Center for Health Technology Assessment (HTA) and Public Health (IZPH), Friedrich-Alexander-Universität Erlangen-Nürnberg, Erlangen, Germany
BMJ Open. 2025 Jan 11;15(1):e087256. doi: 10.1136/bmjopen-2024-087256.
Dementia is one of the most relevant widespread diseases, with a prevalence of currently 55 million people with dementia worldwide. However, about 60-75% of people with dementia have not yet received a formal diagnosis. Asymptomatic screening of cognitive impairments using neuropsychiatric tests has been proven to efficiently enhance diagnosis rates. Digital screening tools, in particular, provide the advantage of being accessible without spatial or time restrictions. The study aims to validate a digital cognitive screening test (digiDEM-SCREEN) as an app in the German language.
This is a multicentre study in Bavaria. Participants are people with mild cognitive impairment, people with dementia in an early stage and cognitively healthy people. Recruitment will take place in specialised diagnostic facilities (memory outpatient clinics). 135 participants are aimed based on a power analysis. Sociodemographic data, diagnosis and results of neuropsychiatric tests (Consortium to Establish a Registry for Alzheimer's Disease, Montreal Cognitive Assessment, digiDEM-SCREEN) will be collected at one point per person via electronic data capturing. The sensitivity, specificity and corresponding cut-off values will be determined based on receiver-operating-characteristic curves. The correlation of the digiDEM-SCREEN test with existing cognitive screening/testing procedures will be analysed.
The study obtained ethical approval from the Ethics Committee of the Julius-Maximilians-Universität of Würzburg (JMU) (application number: 177/23-sc). The test will give feedback about the current cognitive status and possible cognitive impairments that should lead to the users seeking further diagnostic measures by medical professionals. It will be accessible free of charge in established app stores. The results of the validation study will be published in peer-reviewed journals.
痴呆症是最普遍且相关的疾病之一,目前全球有5500万人患有痴呆症。然而,约60 - 75%的痴呆症患者尚未得到正式诊断。使用神经精神测试对认知障碍进行无症状筛查已被证明能有效提高诊断率。特别是数字筛查工具具有不受空间或时间限制即可使用的优势。本研究旨在验证一款德语版数字认知筛查测试应用程序(digiDEM - SCREEN)。
这是一项在巴伐利亚州进行的多中心研究。参与者包括轻度认知障碍者、早期痴呆症患者和认知健康者。招募将在专门的诊断机构(记忆门诊)进行。根据功效分析,目标是招募135名参与者。将通过电子数据采集,每人在一个时间点收集社会人口统计学数据、诊断结果以及神经精神测试(阿尔茨海默病注册协会、蒙特利尔认知评估、digiDEM - SCREEN)的结果。将根据受试者工作特征曲线确定敏感性、特异性及相应的临界值。将分析digiDEM - SCREEN测试与现有认知筛查/测试程序的相关性。
该研究获得了维尔茨堡大学尤利乌斯 - 马克西米利安斯大学伦理委员会(JMU)的伦理批准(申请编号:177/23 - sc)。该测试将提供有关当前认知状态和可能的认知障碍的反馈,这应促使用户寻求医学专业人员的进一步诊断措施。它将在既定的应用商店免费提供。验证研究的结果将发表在同行评审期刊上。